Cellular Responses to Proteasome Inhibition: Molecular Mechanisms and Beyond

Proteasome inhibitors have been actively tested as potential anticancer drugs and in the treatment of inflammatory and autoimmune diseases. Unfortunately, cells adapt to survive in the presence of proteasome inhibitors activating a variety of cell responses that explain why these therapies have not...

Descripción completa

Detalles Bibliográficos
Autores principales: Albornoz, Nicolas, Bustamante, Hianara, Soza, Andrea, Burgos, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678303/
https://www.ncbi.nlm.nih.gov/pubmed/31295808
http://dx.doi.org/10.3390/ijms20143379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678303/
https://www.ncbi.nlm.nih.gov/pubmed/31295808
http://dx.doi.org/10.3390/ijms20143379

Ejemplares similares